[Clinical evaluation of Rhytmodan in heart rhythm disorders].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D004206:Disopyramide / Q000008:administration & dosage / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D011725:Pyridines; D004206:Disopyramide
Ocena kliniczna preparatu Rythmodan w zaburzeniach rytmu serca.